Figure 6 | Scientific Reports

Figure 6

From: The differential effects of tumor burdens on predicting the net benefits of ssCART-19 cell treatment on r/r B-ALL patients

Figure 6

Post-infusion CAR-T cell expansion and the tumor burden. (A) Correlation between chimeric antigen receptor T (CAR-T) cell expansion after infusion and the tumor burden (P = 0.2951). (B) CAR-T cell counts in the blood over the first 44 days after CAR-T cell infusion in patients with a low tumor burden (blue line) compared with patients with a high tumor burden (red line).

Back to article page